2025 Pharmaceutical Patent Cliffs, 3D Printing IP Violations, and Standard Essential Patent Licensing: Challenges, Consequences, and Strategies
In 2025, the pharmaceutical industry faces a monumental patent cliff, with forecasts from reliable sources like Forecast data indicating that about 6.6 percent of the Rx market will be at… Read more »